Avory & Company’s Omnicell OMCL Stock Holding History
Bought
Maintained
Sold
Other funds holding OMCL
NAMI
Avory & Company's OMCL Position: Q2 2026 in Review
Avory & Company reduced its Omnicell (OMCL) stake by 13% in Q2 2026, selling an estimated $420K and leaving 66,730 shares worth $2.77M. The position accounts for 3.46% of the portfolio, ranked #8.
Avory & Company first reported a position in OMCL in Q4 2020 and has held it in 23 quarters since. The position peaked at $19.5M in Q4 2020. 304 funds tracked by Wall St. Rank hold OMCL as of Q2 2026.
- Avory & Company held 66,730 shares of Omnicell worth $2.77M as of Q2 2026.
- Avory & Company sold 10,407 Omnicell shares in Q2 2026, an estimated $420K.
- Omnicell made up 3.46% of Avory & Company's portfolio in Q2 2026, its #8 holding.
- Avory & Company first reported a position in Omnicell in Q4 2020 and has held it in 23 quarters since.
- Avory & Company's Omnicell position peaked at $19.5M in Q4 2020.
- 304 funds tracked by Wall St. Rank held Omnicell as of Q2 2026.
Based on Avory & Company's 13F filing for Q2 2026, filed 23 Jul 2026.